Commentary on Hser et al. (2014): to retain or not to retain-open questions in opioid maintenance therapy.
Department of Psychiatry, Ludwig Maximilian University, Nussbaumstr 7, 80336, Munich, Germany; Private Hospital Meiringen, PO Box 612, 3860, Meiringen, Switzerland.
Michael
M
Soyka
Thomas
T
Hillemacher
D000701:Analgesics, Opioid / Q000627:therapeutic use*; D002047:Buprenorphine / Q000627:therapeutic use*; D000069479:Buprenorphine, Naloxone Drug Combination; D005260:Female; D006801:Humans; D008297:Male; D008691:Methadone / Q000627:therapeutic use*; D009270:Naloxone / Q000627:therapeutic use*; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D058850:Opiate Substitution Treatment / Q000379:methods*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D016903:Drug Monitoring
D000701:Analgesics, Opioid; D000069479:Buprenorphine, Naloxone Drug Combination; D009292:Narcotic Antagonists; D009270:Naloxone; D002047:Buprenorphine; D008691:Methadone
Buprenorphine; methadone; opioid dependence; opioids; therapy